Timothy Edward Lee Adagio Therapeutics, Inc. (ADGI) insider trading activity

ADGI Quotes by TradingView

Timothy Edward Lee is Chief Commercial Officer of Adagio Therapeutics, Inc.. Currently has a direct ownership of 59,344 shares of ADGI, which is worth approximately $196,428. The most recent transaction as insider was on Aug 19, 2025, when has been sold 29,643 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $16,896. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.3K
n/a 3M change
n/a 12M change
Total Value Held $196,428

Timothy Edward Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 19 2025
SELL
Open market or private sale
$16,896 $0.57 p/Share
29,643 Reduced 33.31%
59,344 Common Stock
Aug 18 2025
SELL
Open market or private sale
$13,008 $0.65 p/Share
20,013 Reduced 18.36%
88,987 Common Stock
Aug 15 2025
BUY
Exercise of conversion of derivative security
-
99,000 Added 47.6%
109,000 Common Stock
TEL

Timothy Edward Lee

Chief Commercial Officer
Waltham, MA

Track Institutional and Insider Activities on ADGI

Follow Adagio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADGI shares.

Notify only if

Insider Trading

Get notified when an Adagio Therapeutics, Inc. insider buys or sells ADGI shares.

Notify only if

News

Receive news related to Adagio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADGI